Donald T Beam MD (He/Him)
Pediatric Anemia and Red Blood Cell Hematology, Pediatric Coagulation Disorder Hematology, Pediatric Hematologic Oncology
Chief, Division of Hematology/Oncology and Stem Cell Transplant, Cook Children's Health Care System
Join to View Full Profile
Cook Children's Dodson Specialty Clinics1500 Cooper St 5th FloorFort Worth, TX 76104
Phone+1 682-885-4007
Dr. Beam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Donald Beam is a Pediatric Hematologist and Oncologist based in Fort Worth, TX, specializing in pediatric anemia, red blood cell hematology, coagulation disorders, and hematologic oncology. He completed his residency in Internal Medicine/Pediatrics at Louisiana State University School of Medicine and a fellowship in Pediatric Hematology/Oncology at Duke University Hospital. He serves as the Medical Director at Cook Children's Health Care System and has been an Attending Physician there since 2006. Additionally, he is an Associate Professor at the University of North Texas Health Sciences. Dr. Beam has published several studies on the treatment of immune thrombocytopenia in children and has served as a Principal Investigator in clinical trials related to cardiomyopathy biomarkers, plasma-product exposure, and childhood cancer survivorship.
Education & Training
Duke University HospitalFellowship, Pediatric Hematology/Oncology, 2003 - 2006
Louisiana State University School of MedicineResidency, Internal Medicine/Pediatrics, 1999 - 2003
LSU School of Medicine in ShreveportClass of 1999
Certifications & Licensure
TX State Medical License 2006 - 2026
LA State Medical License 2000 - 2011
NC State Medical License 2003 - 2006
American Board of Internal Medicine Internal Medicine
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Survey of Inhibitors in Plasma-Product Exposed Toddlers Start of enrollment: 2010 Jan 01
- Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment Start of enrollment: 2014 Mar 05
- Childhood Cancer Survivor Study Start of enrollment: 1995 Jan 05
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 3 citationsA single-arm, long-term efficacy and safety study of subcutaneous romiplostim in children with immune thrombocytopenia.John Grainger, James Bussel, Michael Tarantino, Nichola Cooper, Donald Beam
Blood Advances. 2023-02-14 - 7 citationsRomiplostim treatment for children with immune thrombocytopenia: Results of an integrated database of five clinical trialsMichael D. Tarantino, Jenny M. Despotovic, John Roy, John D. Grainger, Nichola Cooper
Pediatric Blood & Cancer. 2020-11-01 - 25 citationsLong-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia.Michael D. Tarantino, James B. Bussel, Victor S. Blanchette, Donald Beam, John Roy
Haematologica. 2019-11-01
Press Mentions
- Five Cook Children’s Specialty Programs Considered Among the Top in the CountryJuly 25th, 2023
Professional Memberships
- Member
- Member
External Links
- Mainhttp://www.cookchildrens.org/SpecialtyServices/HematologyOncology/Pages/default.aspx
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
